Even though some quantitative results, such as E-Cadherin in U87 cells, showed no difference (Fig. 4c and d), we could also draw the conclusion that Smarcd1 inhibited the ability of invasion in glioma cells by combination of the transwell assays and the protein expression tendency. The gene discussed is CDH1; the disease is central nervous system cancer.